Filing Details

Accession Number:
0001209191-17-022762
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-24 16:24:10
Reporting Period:
2017-03-23
Filing Date:
2017-03-24
Accepted Time:
2017-03-24 16:24:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1419600 Flexion Therapeutics Inc FLXN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1129890 W Frederick Driscoll C/O Flexion Therapeutics, Inc.
10 Mall Road, Suite 301
Burlington MA 01803
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-23 3,000 $7.89 10,777 No 4 M Direct
Common Stock Disposition 2017-03-23 3,000 $23.00 7,777 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock option (right to buy) Disposition 2017-03-23 3,000 $0.00 3,000 $7.89
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
102,300 2023-05-19 No 4 M Direct
Footnotes
  1. Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted December 20, 2016.
  2. 1/4 of the shares subject to the option vest one year after May 20, 2013, with 1/48th of the shares vesting monthly thereafter over the next 3 years.